You are here

Category
Technology Name
Briefcase
Scientist
1662
Immunotherapy, that is the use of the immune system to treat cancer, is currently a leading candidate in the combat against cancer. Unlike the toxic effects of both chemotherapy and radiation, immunotherapy is considered to have mild side effects due to its ability to differentiate between healthy and...

Immunotherapy, that is the use of the immune system to treat cancer, is currently a leading candidate in the combat against cancer. Unlike the toxic effects of both chemotherapy and radiation, immunotherapy is considered to have mild side effects due to its ability to differentiate between healthy and cancerous cells. Also, the therapeutic role of the immune system is an essential element in the healing process due to bone marrow transplantation for hematologic malignancies.
However, a more efficacious and less toxic T cells based treatment is required. Effective therapy depends on the functional avidity between T cell receptors (TCRs) and peptide-MHC complex (pMHC). However the natural affinity of TCR is low and they do not naturally undergo the processes that improve antibody affinity, such as somatic hypermutation (SHM). Currently there is no method of increasing the affinity of a TCR to its ligand. Moreover there is no knowledge on how use affinity maturated TCRs for creating anti-tumor reactive cells
This technology presents a method of increasing the affinity of a TCR to its ligand. This is done by subjecting TCR genes to SHM via the enzyme Activation Induced cytidine Deaminase (AID). The technology further provides affinity maturated TCRs (in cell- bound or in soluble form) and their pharmaceutical potential for immunotherapy. 

Applications


  • Generating anti-tumor T cells
  • Generating T cells reactive against selected antigen

Advantages


  • Rapid
  • Effective

Technology's Essence


This novel technology reveals that the affinity of a TCR to its ligand may be increased remarkably by subjecting TCR genes to SHM, directed by AID.
First a nucleic acid construct encoding a TCR gene is expressed in a host cell. Next SHM is used to introduce mutations to the TCR gene. Last, the the cells will be analyzed for affinity maturation by tetramer staining and subsequently sorted by FACS.
There are three parallel approaches to perform affinity maturation for the TCR: (1) Ex-vivo affinity maturation system, using Tet-regulated expression of AID (2) Ex-vivo affinity maturation system, using controlled expression of AID by mRNA electrophoresis (3) In-vitro affinity maturation system, using extracts from cells that are in SHM and recombinant AID.

+
  • Prof. Rachel Lea Eisenbach
1546
Improvement of protein production by modulating the tRNA pool. For maximal heterologous expression of proteins per host cell, the optimal level of expression of genes needs to be addressed. The science and art of expressing a gene from one species in another often amounts to modifying the codons of the...

Improvement of protein production by modulating the tRNA pool. For maximal heterologous expression of proteins per host cell, the optimal level of expression of genes needs to be addressed. The science and art of expressing a gene from one species in another often amounts to modifying the codons of the gene, and supplementing the host with specific tRNAs. Yet the full challenge of heterologous expression is not only to maximize expression per host cell, but also to minimize the burden on the host. The outlined invention describes a universally conserved profile of translation efficiency along mRNAs, based on the adaptation between coding sequences and the tRNA pool, to improve heterologous gene expression and thus protein production.

Applications


  • Improvement of the yield and success rate of recombinant protein production.

Advantages


  • Protein expression levels can be artificially increased
  • Minimization of the burden on the host

Technology's Essence


The translation efficiency profile of a gene is defined, for each codon position, as the estimated availability of the tRNAs that participate in translating that codon. The profile is high at codons that correspond to abundant tRNAs and low at codons that correspond to rare tRNAs. In this invention it is predicted that the first ~30-50 codons of genes appear to be translated with a low efficiency “ramp”, while the last ~50 codons show highest efficiency. The “ramp” serves as a late stage of initiation and is an optimal and robust means to reduce ribosomal traffic jams, thus minimizing occupation of free ribosomes, ribosomal abortions and, ultimately, the cost of protein expression. Implementation of appropriate ramping in heterlogous proteins, given the host?s tRNA pool, might improve the yield of expressed recombinant proteins.

+
  • Prof. Yitzhak Pilpel
1602
A novel technology for robust downregulation of bacterial genes.RNAi (RNA interference) is a powerful method for downregulation of gene expression in eukaryotic systems. RNAi-based technologies are extensively applied as scientific research tools, as well as actively explored as promising therapeutic...

A novel technology for robust downregulation of bacterial genes.RNAi (RNA interference) is a powerful method for downregulation of gene expression in eukaryotic systems. RNAi-based technologies are extensively applied as scientific research tools, as well as actively explored as promising therapeutic agents. However, although an efficient way to dowregulate bacterial and microbial gene expression has been long sought after, RNAi is not applicable in these species. The present technology offers a rapid and simple means to silence gene products in prokaryotic systems.

Applications


  • Treatment of bacterial infection, by targeting bacterial genes vital for antibiotic resistance or bacterial virulence.
  • Enhanced biofuel production by targeting genes that interfere with ethanol and/or hydrogen biosynthesis.
  • Generation of improved bacterial strains for the diary industry (e.g. phage-resistant strains).
  • Discerning prokaryotic gene function by silencing the expression of the gene product.

Advantages


  • The present technology may offer means to treat antibiotics-resistant strains.
  • Because CRISPR-based technology does not involve ‘classical’ genetic engineering, the resulting products do not require labeling as 'genetically modified'.
  • CRISPR-based technology system allows for the development of a rapid, scalable and high-throughput platform to probe the function of genetic circuits in prokaryotes.

Technology's Essence


CRISPR (clusters of regularly interspaced short palindromic repeats) is a recently discovered anti-viral system that functions as the prokaryotic-equivalent of the adaptive immune system. CRISPR provides bacteria with protection against foreign genetic elements such as viruses by incorporating short stretches of invading DNA sequences in genomic CRISPR loci. These integrated sequences are thought to function as a genetic memory that prevents the host from being infected by the viruses and other genetic elements containing this recognition sequence. A team of researchers at the Weizmann Institute, headed by Dr. Rotem Sorek, has developed a unique technology to gain robust and rapid silencing of prokaryotic gene expression by exploiting the CRISPR system capacity to efficiently downregulate gene products. This potent technology can potentially be utilized in a broad range of areas such as in the agriculture, food and pharmaceutical industries as well as in the scientific research arena.

+
  • Prof. Rotem Sorek
1583
The thermoelectric effect is the direct conversion of temperature differences to electric voltage and vice versa. Thermoelectric effects are used in various applications, where heat energy is saved, that would be otherwise lost. Although the TE conversion efficiency is nowadays low (5-8%), the novel...

The thermoelectric effect is the direct conversion of temperature differences to electric voltage and vice versa. Thermoelectric effects are used in various applications, where heat energy is saved, that would be otherwise lost. Although the TE conversion efficiency is nowadays low (5-8%), the novel technique developed at Weizmann Institute, has a disruptive potential to change this market.  

Prof. Y. Imry and his team at Weizmann Institute came up with Thermal Electric conversion technique, based on a new TE device architecture which allows performance enhancement. The core invention is in the field of Bi-junction thermoelectric device architecture, having a thermoelectric gate interposed between two electric regions, leading to thermal electric conversion efficiency optimization.

Applications


Various TE devices will benefit from better TE efficiency, achieved by the developed conversion technique. The growing market for thermoelectric energy harvesters will reach $865 million by 2023. Current TE market is driven by consumer energy harvesting applications and some niche segments:

  •  Automotive energy harvesting applications, since around 40% of the energy produced by internal combustion engines is currently lost in heat through the exhaust.
  • Wireless devices/sensors segment is forecasted to account for over a third of the overall market for thermoelectric harvesters and cooling by 2023.

Advantages


In order to drive down the thermoelectric module costs and facilitate broad deployment, TE has several barriers to overcome: 

  •  low conversion efficiency;
  • toxicity and low availability of chemical elements constituting part of the thermoelectric materials.

 In this context, the main TE market challenges are reaching higher efficiencies using low cost thermoelectric materials. These challenges can be addressed by the proposed technology.


Technology's Essence


Prof. Y. Imry and his team at Weizmann Institute have developed novel bi-junction TE device, having a thermoelectric gate interposed between two electric regions, aiming at TE efficiency improvement. Thermoelectric efficiency depends on the figure of merit (ZT). The figure-of-merit curves, for the developed 3-T TE device configurations show that higher ZT should be achieved.  

The secret essence of the invented configuration is in using two independently adjustable input parameters - voltage and temperature - as drivers for optimizing device thermoelectric efficiency.

 

+
  • Prof. Yoseph Imry
1640
Although early programs targeting MMPs (matrix metalloproteins) were largely unsuccessful due to adverse side effects, they remain a viable and highly desirable therapeutic target. The main obstacle in the attempts to target MMPs is the ability to selectively target individual family members. The...

Although early programs targeting MMPs (matrix metalloproteins) were largely unsuccessful due to adverse side effects, they remain a viable and highly desirable therapeutic target. The main obstacle in the attempts to target MMPs is the ability to selectively target individual family members. The present invention provides highly selective targeted therapy against MMP-7, which is strongly associated with aspects of cancer development such as angiogenesis and metastasis.
The innovative concept leading to this high selectivity is immunization with both a synthetic metal-protein mimicry molecule, previously developed by the present inventors, followed by the metalloenzyme itself (e.g. MMP-7). The resulting antibody exhibits exceptional degree of specificity towards MMP-7 over other MMPs.
The present technology offers an opportunity to re-introduce improved MMP-targeting agents to the cancer therapeutics market, in particular aggressive cancers that face a major unmet medical need. 

Applications


  • Therapy for MMP-7 associated diseases
  • Diagnostic tool for MMP-7 associated diseases

Advantages


  • Highly selective
  • Safe – avoids adverse effects that are associated with broad spectrum MMP inhibitors.
  • Efficient – targeting a physiological active conformation of the enzyme

Technology's Essence


The present technology is based on a previous invention that was developed in Prof. Sagi's lab, of synthetic metal-protein mimicry molecules that mimic the conserved structure of the metalloenzyme catalytic zinc-histidine complex within the active site of each MMP enzyme.
These molecules were shown to be powerful immunogens in the generation of highly selective MMP antibodies since they recognize both electrical and structural determinants residing within the enzyme active site. The potential of this method to successfully generate MMP-targeting therapeutics was shown for MMP-9/2 inhibitory antibodies in mouse models of inflammatory bowel disease.
Prof Sagi and her team now take this invention a step further to achieve even higher specificity. They show that immunizing with the mimicking molecules described above, followed by immunization with the metalloenzyme itself increases selectivity further.   
Implemented for MMP-7-targeting, this approach yielded an antibody with a 5 fold lower Ki towards MMP-7 than towards other MMPs (e.g. MMp-2 and MMP-9).


 

+
  • Prof. Irit Sagi
  • Prof. Irit Sagi
1554
We present a novel approach resulting in efficient and robust wireless energy transfer in the mid-range. Applications of wireless energy transfer are already in use and are continuously being developed. The main limit of wireless energy transfer techniques is that both the transmitter and transformer...

We present a novel approach resulting in efficient and robust wireless energy transfer in the mid-range. Applications of wireless energy transfer are already in use and are continuously being developed. The main limit of wireless energy transfer techniques is that both the transmitter and transformer need to be of the same resonance. In addition, this technique is very susceptible to noise which limits efficiency. The present invention provides a technique for a robust and efficient mid-range wireless power transfer between two coils. This technique can transfer the energy between the coils without being sensitive to any resonant constrains, noise and other interferences that exist in the neighborhood of the coils

Applications


  • Simultaneous energy transfer to several electrical gadgets.

Advantages


  • Efficient
  • Not sensitive to electrical interference.
  • No need for an exact resonance match between transmitter and transformer.

Technology's Essence


The efficiency and robustness of this technology is achieved by adapting the process of rapid adiabatic passage (RAP) for a coherently driven two state atom to the field of wireless energy transfer. In other words, the resonance of the transmitter is tuned adiabatically to scan a resonant frequency range, thus arriving at a dynamic solution to the electrical transfer problem.

+
  • Prof. Yaron Silberberg
1610
A novel method for increasing Insulin content in pancreatic beta cells. In healthy individuals, Insulin is produced by beta cells of the pancreas. In people with type 1 diabetes mellitus (T1DM), these cells do not produce enough Insulin to effectively fine-tune blood sugar levels. In the US alone...

A novel method for increasing Insulin content in pancreatic beta cells.

In healthy individuals, Insulin is produced by beta cells of the pancreas. In people with type 1 diabetes mellitus (T1DM), these cells do not produce enough Insulin to effectively fine-tune blood sugar levels. In the US alone there are up to 3 million affected individuals with 30,000 new cases diagnosed each year. Worldwide, T1DM incidence has been increasing in recent years by 2% to 5%. Traditionally treated by multiple daily injections of recombinant Insulin, T1DM management represents a significant burden to both patients and the healthcare system. Recent data estimate that T1DM costs the US ~$15 billion annually in medical costs and lost income. Thus, novel therapeutic approaches to amplify Insulin production in diseased beta cells or to replace them entirely are in great need. The present technology describes a cell-based method to enhance beta cell differentiation and Insulin production by the downregulation of a pancreas-enriched microRNA.

 

Applications


  • Cell replacement therapy: directed differentiation of stem cells towards a beta cell fate followed by transplantation of these engineered cells into patients.
  • These methods can potentially be applied to other Insulin deficiency-related conditions such as diabetes mellitus type 2, metabolic syndrome and obesity.

Advantages


  • Simple and robust method for accelerating beta cell differentiation.
  • Cell base therapy for diabetes.
  • Increasing Insulin level.

Technology's Essence


A research team headed by Dr. Hornstein from the Weizmann Institute has discovered an essential role for microRNA-7 (miR-7), a microRNA that is highly and selectively expressed in the endocrine pancreas, in the regulation of beta cell differentiation. By down-regulating the expression of miR-7, the researchers were able to accelerate beta cell differentiation, and concomitantly to augment their Insulin production rate. The data gained from these studies can be further utilized in cell-based therapy applications to restore Insulin production in damaged beta cells, or alternately to replace these cells with stem cells coaxed to differentiate towards a beta cell fate.

 

+
  • Dr. Eran Hornstein
1644
Computer memory and storage are among the most critical components of today’s consumer electronics and computer technology. Currently available memory and storage technologies have inherent limitations that confine the capacity and speed of access to memory devices. The present innovation is based on...

Computer memory and storage are among the most critical components of today’s consumer electronics and computer technology. Currently available memory and storage technologies have inherent limitations that confine the capacity and speed of access to memory devices.

The present innovation is based on Chiral Induced Spin Selectivity (CISS) effect that was established experimentally and theoretically in the last decade, and allows for production of inexpensive, high-density universal memory-on-chip devices, that don’t require the use of permanent magnets.

Applications


·         Inexpensive, high-density universal memory-on-chip devices

·         The technology can be used as superior alternative for both Random Access memory and Flash memory

·         Surface-controlled spintronic devices

·         Logic and data processing


Advantages


·         Up to 70 times more storage on the same physical size

·         Up to 100 times lower energy consumption

·         Si-Compatible

·         High density (can reach Si technology limit)

·         Estimated low cost

·         Overcomes limitations of other magnetic-based memory technologies


Technology's Essence


Ferromagnets can be magnetized either by external magnetic fields or by spin polarized current. However, the current density required for inducing magnetization is extremely high and significantly affects the device’s structure and performance. The newly discovered CISS effect allows for magnetization switching of Ferromagnets, which is induced solely by adsorption of chiral molecules, where much lower current density is sufficient to induce the magnetization reversal. Chiral Memory technology uses the CISS effect for spin selectivity instead of the common ferromagnetic-based spin filters. This allows, in principle, the memory bit to be miniaturized down to a single magnetic nanoparticle or a nano-scale domain. The operation principle of the device relies on the spin-selective transmission of electrons through organic chiral molecules to the ferromagnetic layer of the device, which results in the magnetization of this layer and efficient storing of bits of information. The magnetization switching by local adsorption of chiral molecules eliminates the need for a permanent magnet.

+
  • Prof. Ron Naaman
1587
An innovative technique to preserve and prolong shelf-life in crop-plants cost-effectively. Different agricultural crops from Solanaceous species which include tomato, potato and eggplant, overcome oxidative stress by the production of steroidal glycoalkaloids (SGAs) and steroidal saponins. Although...

An innovative technique to preserve and prolong shelf-life in crop-plants cost-effectively.
Different agricultural crops from Solanaceous species which include tomato, potato and eggplant, overcome oxidative stress by the production of steroidal glycoalkaloids (SGAs) and steroidal saponins. Although SGAs contribute to plant resistance to a wide range of pathogens and predators some are considered as toxic to humans, with potato known as most relevance to food safety.
This innovative technology offers improvement  of nutritional composition and prolonged shelf-life of Solanaceous species, which are widely consumed crop-plants with a market size of hundreds of billions of tones produced yearly worldwide.

Applications


Modification of steroidal glycoalkaloids and steroidal saponins compounds in plants can be used for two purposes:
1. Widely used crop-plants from Solanaceae species with reduced anti-nutritional components.  Leading to a longer shelf-life of crop-plants with safer nutritional compounds. 
2. Highly resistant modified plant with enriched toxic steroidal glycoalkaloids content for non-edible usage. 

Advantages


  • Prolongs shelf-life- by preventing post-harvest elevated toxicity levels.
  • Reduction of undesired anti-nutritional alkaloids, by means that do not affect other biological plant pathways.
  • Helps avoiding spoilage and toxicity of plants that manifest during storage and process.
  • Stress and pathogen-resistant plants for non-edible usage: Genetically modified plants with elevated toxic steroidal glycoalkaloids content will result in enhanced resistance to stress related factors. The outcome will also be prolonged shelf-life achieved in a clean economic manner (reduced need of pesticides/ insecticides).

Technology's Essence


The invention relates to key genes and enzymes on the biosynthesis pathway converting cholesterol to SGA. Biosynthesis involves an array of genes. Modulation of specific regulatory, transcription factor genes had enabled strict control of the production of steroidal alkaloids and glycosylated derivatives therefore.
Prof. Asaph Aharoni discovered the key genes in the biosynthesis of steroidal saponins and steroidal alkaloids in his lab at the Weizmann institute. He also developed a method for altering the gene expression and the production (reduction or elevation) of these components in plants from the Solanaceae species.

+
  • Prof. Asaph Aharoni
1556
Synthetic carbon fixation pathways can allow plants to produce more biomass using the same amount of energy from sunlight. Novel carbon fixation cycles discovered at The Weizmann Institute hold potential to greatly increase the capacity of organisms to convert atmospheric carbon into sugars. Modern...

Synthetic carbon fixation pathways can allow plants to produce more biomass using the same amount of energy from sunlight. Novel carbon fixation cycles discovered at The Weizmann Institute hold potential to greatly increase the capacity of organisms to convert atmospheric carbon into sugars.

Modern agriculture faces limited arable land and climate changes. Carbon fixation under these conditions will become a significant growth limiting factor. The proposed solution provides the ability to enhance crop yields using the same expanse of land.

The novel technology presents alternative synthetic carbon fixation pathways that were discovered by harnessing a systems biology approach. These pathways are predicted to harbor a significant kinetic advantage over their natural counter parts, making them promising candidates for synthetic biology implementation.

Applications


  • Synthetic organisms utilizing this revolutionary technology can offer higher carbon fixation rates as compared to natural alternatives allowing:
  • Superior rate of biomass generation, providing cost effective feedstock for the production of biofuels.
  • Enhanced food production via increased crop yields.

Advantages


  • Minimal thermodynamic bottlenecks and superior kinetics over natural counterparts.

Technology's Essence


The productivity of carbon fixation cycles is limited by the slow rate and lack of substrate specificity of the carboxylating enzyme, RuBisCo. In his discovery Dr. Milo addresses the inefficiency of the carbon fixation process through an alternative cycle that is predicted to be two to three times faster than the Calvin–Benson cycle, employing the most effective carboxylating enzyme, phosphoenolpyruvate carboxylase, using the core of the naturally evolved C4 cycle.

A computational strategy was applied, comparing kinetics, energetic and topology of all the possible pathways that can be assembled from all ~4,000 metabolic enzymes known in nature.

The results suggest a promising new family of synthetic carbon fixation pathways.

+
  • Prof. Ron Milo
1616
Existing treatments against cancer are non-sufficiently selective. Immunotherapy based treatment offers highly selective and efficient solution to this problem. A promising approach in Immunotherapy is adoptive cell therapy (ACT). In ACT, therapeutic lymphocytes are administrated to patients in order...

Existing treatments against cancer are non-sufficiently selective. Immunotherapy based treatment offers highly selective and efficient solution to this problem.
A promising approach in Immunotherapy is adoptive cell therapy (ACT). In ACT, therapeutic lymphocytes are administrated to patients in order to treat a disease. In this process antibody-type cells are generated ex vivo, and then infused to the patient. By this technology the cells can be redirected against specific tumors via genetic engineering, using chimeric receptors.
Currently ACT is logistically and economically challenging since it is limited by the used of the patients’ own cells. Another key concern is safety, due to the danger that the allogeneic cells will be rejected by the patient, or will attack the patient.
In cancer, use of tumor specific, chimeric receptor redirected allogeneic T cells can transform ACT into a standardized, off-the shelf therapy. Overall this method proposes a safe and effective adoptive therapy using allogeneic cells while avoiding the use of bone marrow transplantation (BMT).

Applications


  • Cancer immunotherapy

Advantages


  • Off the shelf, standard treatment
  • Safe
  • Effective
  • No bone marrow transplantation (BMT) is required

Technology's Essence


A novel approach for adoptive immunotherapy using fully MHC-mismatch allogeneic T cells. These cells are redirected with tumor specific non-MHC-restricted antibody-based chimeric antigen receptor (T-bodies) in the absence of Graft-versus-host disease (GVHD). In order to create a standardize treatment, the redirection of T cells can be done through an antibody-based chimeric antigen receptor (CAR), thus creating ‘universal effector T cells’. This is based on a combination of of MHC-mismatched allogeneic T-cells with an MHC unrestricted chimeric antigen receptor. These cells would recognize their target independently of MHC restriction, therefore applied as an ‘off-the shelf’ immunotherapy. Regarding the second challenge of avoiding GVHD, by using a controlled lymphodepletion the researchers were able to create therapeutic window during which the allo-T-body cells could destroy the tumor before being themselves rejected.

+
  • Prof. Zelig Eshhar
1522
A method for enhancing the spatial and or temporal resolution (if applicable) of an input signal such as images and videos.   Many imaging devices produce signals of unsatisfactory resolution (e.g. a photo from a cell-phone camera may have low spatial resolution or a video from a web camera may have...

A method for enhancing the spatial and or temporal resolution (if applicable) of an input signal such as images and videos.

 

Many imaging devices produce signals of unsatisfactory resolution (e.g. a photo from a cell-phone camera may have low spatial resolution or a video from a web camera may have both spatial and temporal low resolution). This method applies digital processing to reconstruct more satisfactory high resolution signals.

 

Previous methods for Super-Resolution (SR) require multiple images of the same scene, or else an external database of examples. This method provides the ability to perform SR from a single image (or a single visual source). The algorithm exploits the inherent local data redundancy within visual signals (redundancy both within the same scale, and across different scales).

 

Examples of the methods' capabilities can be found here: http://www.wisdom.weizmann.ac.il/~vision/SingleImageSR.html

 

Applications


  • Enhancing the spatial resolution of images

  • Enhancing the spatial and or temporal resolution of video sequences

  • Enhancing the spatial and or temporal resolution (if applicable) of other signals (e.g., MRI, fMRI, ultrasound, possibly also audio, etc.)

 


Advantages


  • No need for multiple low resolution sources or the use of an external database of examples.

  • Superior results are produced due to exploitation of inherent information in the source signal.


Technology's Essence


The framework combines the power of classical multi image super resolution and example based super resolution. This combined framework can be applied to obtain super resolution from as little as a single low-resolution signal, without any additional external information. The approach is based on an observation that patches in a single natural signal tend to redundantly recur many times inside the signal, both within the same scale, as well as across different scales.

Recurrence of patches within the same scale (at subpixel misalignments) forms the basis for applying the 'classical super resolution' constraints to information from a single signal. Recurrence of patches across different (coarser) scales implicitly provides examples of low-resolution / high-resolution pairs of patches, thus giving rise to 'example-based super-resolution' from a single signal (but without any external database or any prior examples).

+
  • Prof. Michal Irani
1245

Applications


The novel DNA Aptamer is a promising candidate for therapeutic as well as diagnostic uses: Therapeutic: A novel therapy for Influenza Diagnostics: Detection of Influenza infection in vertebrates such as avian, swine and human

Technology's Essence


Scientists at the Weizmann Institute of Science describe a novel oligonucleotide, also known as an Aptamer, which has been designed to complement the receptor-binding region of the influenza haemagglutinin molecule. It was constructed by screening a DNA library and processing by the SELEX procedure. This DNA Aptamer comprises of a polynucleotide sequence that can bind to a polypeptide within the binding region of the influenza virus to the host cell. The proposed mode of action of this Aptamer is by blocking the binding of influenza virus to target cell receptors and consequently preventing the virus invasion into the host cells. Aptamer is capable of inhibiting the haemagglutinin capacity of the virus and the viral infectivity in vitro. Furthermore, it was shown in an animal model to inhibit viral infection by different influenza strains, as manifested by up to 99% reduction of virus burden in the lungs of treated mice.

+
  • Prof. Ruth Arnon
1481
In recent years, there has been a growing interest in the development of nanoscale magnetic and thermal characterization tools in order to address rapidly evolving fields, such as nanomagnetism, spintronics and energy-efficient computing. The requirements from these tools include high sensitivity and...

In recent years, there has been a growing interest in the development of nanoscale magnetic and thermal characterization tools in order to address rapidly evolving fields, such as nanomagnetism, spintronics and energy-efficient computing. The requirements from these tools include high sensitivity and high spatial resolution to enable local detection and accurate measurements of extremely low signals. For example, the energy dissipation mechanism in quantum systems is related to preservation of quantum information, which is of particular importance in the field of quantum computing. Available local magnetic imaging methods suffer from low sensitivity and in some cases, low spatial resolution. On the other hand, energy dissipation is not a readily measurable quantity on the nanometer scale and existing thermal imaging methods are not sensitive enough for studying quantum systems and are unsuitable for low temperature operation.

A novel sensor device comprising a nanoscale superconducting quantum interference device (SQUID) was developed by Prof. Zeldov at the Weizmann Institute of Science. The fabrication method enables the miniaturization of the sensor to an effective diameter of below 50 nm and its integration onto the apex of a very sharp tip that is ideally suited for scanning probe microscopy. The extremely small size of the SQUID-on-tip sensor and the ability to approach very close to the sample surface result in nano-metric spatial resolution and a very sensitivity.

Applications


·         Scanning probe microscopy for magnetic and thermal characterization

·         Inspection and probing equipment for quantum computing


Advantages


  • Simple fabrication process

  • High field sensitivity and bandwidth

  • Nanoscale sensors (down to 46 nm in diameter)

  • Tip-sample distance can be as close as a few nanometers


Technology's Essence


A SQUID is a very sensitive magnetometer used to measure extremely subtle magnetic fields, based on superconducting loops. The present invention is a novel sensor device, based on a nanoscale two-junction or multi-junction SQUIDs fabricated on the edge of a sharp tip in a three dimensional geometric configuration. In such a setup, the SQUID can approach the sample to a distance of few nanometers, as opposed to the conventional planar SQUIDs, which results in an extremely high sensitivity.

+
  • Prof. Eli Zeldov
1392
A catalytic based reaction for the treatment of industrial waste water. Millions of tons of organic chemical compounds - including solvents, petrochemicals, agrochemicals, and pharmaceuticals - are produced every year by a wide variety of chemical industries. Two immediate problems arise: 1. Industrial...

A catalytic based reaction for the treatment of industrial waste water. Millions of tons of organic chemical compounds - including solvents, petrochemicals, agrochemicals, and pharmaceuticals - are produced every year by a wide variety of chemical industries. Two immediate problems arise: 1. Industrial production of these chemicals and/or other products leads to effluent streams - highly toxic, contaminated aqueous solutions - from factories. These effluents must be treated prior to release of the water back into the environment. 2. Following use, these chemicals (e.g., agrochemicals, pharmaceuticals) become serious pollutants as they eventually find their way into the soil, sediment, and surface and/or groundwater environments. Current treatment methods are severely limited. Treatment of effluent streams by, e.g., filtration, photocatalysis, or bioreactors is often highly ineffective - the waste compounds not being easily captured, degraded or transformed - and/or prohibitively expensive.

Applications


  • Detoxification of industrial effluents, especially from petrochemical, agrochemical and pharmaceutical industries 
  • Waste water decontamination 
  • In situ and ex situ remediation of water polluted by organic and other contaminants

Advantages


  • Cost efficient
  • Quick

Technology's Essence


Researchers at the Weizmann Institute of Science have developed a new process for degradation and/or treatment of practically any organic contaminant in aqueous solutions under oxidizing (aerobic) conditions. A suite of catalytic materials has been developed which allows both in situ and ex situ remediation of polluted water by oxidative chemical degradation of contaminants. The technology eliminates or reduces a broad range of water pollutants - industrial organic solvents, petrochemicals, agrochemicals and pharmaceuticals (e.g., endocrine disruptors such as antiobiotics and hormones) - and is particularly effective for treating concentrated industrial effluents, under technically convenient conditions. The reaction products consist essentially of benign materials.

+
  • Prof. Brian Berkowitz

Pages